This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanglard, D.
Right arrow Articles by Bille, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanglard, D.
Right arrow Articles by Bille, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 11 1995, 2378-2386, Vol 39, No. 11
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

D Sanglard, K Kuchler, F Ischer, JL Pagani, M Monod and J Bille
Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Azole antifungal agents, and especially fluconazole, have been used widely to treat oropharyngeal candidiasis in patients with AIDS. An increasing number of cases of clinical resistance against fluconazole, often correlating with in vitro resistance, have been reported. To investigate the mechanisms of resistance toward azole antifungal agents at the molecular level in clinical C. albicans isolates, we focused on resistance mechanisms related to the cellular target of azoles, i.e., cytochrome P450(14DM) (14DM) and those regulating the transport or accumulation of fluconazole. The analysis of sequential isogenic C. albicans isolates with increasing levels of resistance to fluconazole from five AIDS patients showed that overexpression of the gene encoding 14DM either by gene amplification or by gene deregulation was not the major cause of resistance among these clinical isolates. We found, however, that fluconazole-resistant C. albicans isolates failed to accumulate 3H-labelled fluconazole. This phenomenon was reversed in resistant cells by inhibiting the cellular energy supply with azide, suggesting that resistance could be mediated by energy-requiring efflux pumps such as those described as ATP-binding cassette (ABC) multidrug transporters. In fact, some but not all fluconazole-resistant clinical C. albicans isolates exhibited up to a 10-fold relative increase in mRNA levels for a recently cloned ABC transporter gene called CDR1. In an azole-resistant C. albicans isolate not overexpressing CDR1, the gene for another efflux pump named BENr was massively overexpressed. This gene was cloned from C. albicans for conferring benomyl resistance in Saccharomyces cerevisiae. Therefore, at least the overexpression or the deregulation of these two genes potentially mediates resistance to azoles in C. albicans clinical isolates from AIDS patients with oropharyngeal candidiasis. Involvement of ABC transporters in azole resistance was further evidenced with S. cerevisiae mutants lacking specific multidrug transporters which were rendered hypersusceptible to azole derivatives including fluconazole, itraconazole, and ketoconazole.


This article has been cited by other articles:

  • Rodaki, A., Bohovych, I. M., Enjalbert, B., Young, T., Odds, F. C., Gow, N. A.R., Brown, A. J.P. (2009). Glucose Promotes Stress Resistance in the Fungal Pathogen Candida albicans. Mol. Biol. Cell 20: 4845-4855 [Abstract] [Full Text]  
  • Arana, D. M., Nombela, C., Pla, J. (2009). Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes. J Antimicrob Chemother 0: dkp407v1-dkp407 [Abstract] [Full Text]  
  • Sionov, E., Chang, Y. C., Garraffo, H. M., Kwon-Chung, K. J. (2009). Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence. Antimicrob. Agents Chemother. 53: 2804-2815 [Abstract] [Full Text]  
  • Posteraro, B., Martucci, R., La Sorda, M., Fiori, B., Sanglard, D., De Carolis, E., Florio, A. R., Fadda, G., Sanguinetti, M. (2009). Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata. J. Clin. Microbiol. 47: 1927-1930 [Abstract] [Full Text]  
  • Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., Monk, B. C. (2009). Efflux-Mediated Antifungal Drug Resistance. Clin. Microbiol. Rev. 22: 291-321 [Abstract] [Full Text]  
  • Tsao, S., Rahkhoodaee, F., Raymond, M. (2009). Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance. Antimicrob. Agents Chemother. 53: 1344-1352 [Abstract] [Full Text]  
  • Ramsdale, M., Selway, L., Stead, D., Walker, J., Yin, Z., Nicholls, S. M., Crowe, J., Sheils, E. M., Brown, A. J.P. (2008). MNL1 Regulates Weak Acid-induced Stress Responses of the Fungal Pathogen Candida albicans. Mol. Biol. Cell 19: 4393-4403 [Abstract] [Full Text]  
  • Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhauser, J., Rogers, P. D. (2008). A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate. Eukaryot Cell 7: 1180-1190 [Abstract] [Full Text]  
  • Coste, A. T., Ramsdale, M., Ischer, F., Sanglard, D. (2008). Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. Microbiology 154: 1491-1501 [Abstract] [Full Text]  
  • Manoharlal, R., Gaur, N. A., Panwar, S. L., Morschhauser, J., Prasad, R. (2008). Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans. Antimicrob. Agents Chemother. 52: 1481-1492 [Abstract] [Full Text]  
  • Oliver, B. G., Song, J. L., Choiniere, J. H., White, T. C. (2007). cis-Acting Elements within the Candida albicans ERG11 Promoter Mediate the Azole Response through Transcription Factor Upc2p. Eukaryot Cell 6: 2231-2239 [Abstract] [Full Text]  
  • Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhauser, J., Nantel, A., Raymond, M., Rogers, P. D. (2007). Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon. Eukaryot Cell 6: 2122-2138 [Abstract] [Full Text]  
  • Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., Sanglard, D. (2007). Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates. Eukaryot Cell 6: 1889-1904 [Abstract] [Full Text]  
  • Lamping, E., Monk, B. C., Niimi, K., Holmes, A. R., Tsao, S., Tanabe, K., Niimi, M., Uehara, Y., Cannon, R. D. (2007). Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 6: 1150-1165 [Abstract] [Full Text]  
  • Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., Nguyen, M. H. (2007). A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole. Antimicrob. Agents Chemother. 51: 1855-1858 [Abstract] [Full Text]  
  • Pardini, G., De Groot, P. W. J., Coste, A. T., Karababa, M., Klis, F. M., de Koster, C. G., Sanglard, D. (2006). The CRH Family Coding for Cell Wall Glycosylphosphatidylinositol Proteins with a Predicted Transglycosidase Domain Affects Cell Wall Organization and Virulence of Candida albicans. J. Biol. Chem. 281: 40399-40411 [Abstract] [Full Text]  
  • Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., Sanglard, D. (2006). Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology 152: 3701-3722 [Abstract] [Full Text]  
  • Hiller, D., Stahl, S., Morschhauser, J. (2006). Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate.. Antimicrob. Agents Chemother. 50: 2300-2308 [Abstract] [Full Text]  
  • Andes, D., Forrest, A., Lepak, A., Nett, J., Marchillo, K., Lincoln, L. (2006). Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole and Candida albicans.. Antimicrob. Agents Chemother. 50: 2374-2383 [Abstract] [Full Text]  
  • Saini, P., Gaur, N. A., Prasad, R. (2006). Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p.. Microbiology 152: 1559-1573 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Sheehan, D. J. (2006). Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing. Clin. Microbiol. Rev. 19: 435-447 [Abstract] [Full Text]  
  • Hiller, D., Sanglard, D., Morschhauser, J. (2006). Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans.. Antimicrob. Agents Chemother. 50: 1365-1371 [Abstract] [Full Text]  
  • Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., Sanglard, D. (2006). A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans. Genetics 172: 2139-2156 [Abstract] [Full Text]  
  • Miyazaki, T., Miyazaki, Y., Izumikawa, K., Kakeya, H., Miyakoshi, S., Bennett, J. E., Kohno, S. (2006). Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance. Antimicrob. Agents Chemother. 50: 580-586 [Abstract] [Full Text]  
  • Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., Fadda, G. (2006). Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans. Infect. Immun. 74: 1352-1359 [Abstract] [Full Text]  
  • Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A. R., Maiden, M. C. J., Odds, F. C. (2005). Population Structure and Properties of Candida albicans, as Determined by Multilocus Sequence Typing. J. Clin. Microbiol. 43: 5601-5613 [Abstract] [Full Text]  
  • Pina-Vaz, C., Rodrigues, A. G., Costa-de-Oliveira, S., Ricardo, E., Mardh, P.-A. (2005). Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 56: 678-685 [Abstract] [Full Text]  
  • Park, Y.-N., Morschhauser, J. (2005). Tetracycline-Inducible Gene Expression and Gene Deletion in Candida albicans. Eukaryot Cell 4: 1328-1342 [Abstract] [Full Text]  
  • Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., White, T. C. (2005). Drug-Induced Regulation of the MDR1 Promoter in Candida albicans. Antimicrob. Agents Chemother. 49: 2785-2792 [Abstract] [Full Text]  
  • Saini, P., Prasad, T., Gaur, N. A., Shukla, S., Jha, S., Komath, S. S., Khan, L. A., Haq, Q. Mohd. R., Prasad, R. (2005). Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. J Antimicrob Chemother 56: 77-86 [Abstract] [Full Text]  
  • Kudo, M., Ohi, M., Aoyama, Y., Nitahara, Y., Chung, S.-K., Yoshida, Y. (2005). Effects of Y132H and F145L Substitutions on the Activity, Azole Resistance and Spectral Properties of Candida albicans Sterol 14-Demethylase P450 (CYP51): A Live Example Showing the Selection of Altered P450 through Interaction with Environmental Compounds. J Biochem 137: 625-632 [Abstract] [Full Text]  
  • Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G., Coleman, D. C., Sullivan, D. J. (2005). Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression. Antimicrob. Agents Chemother. 49: 1312-1318 [Abstract] [Full Text]  
  • Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., Cannon, R. D. (2004). Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J Antimicrob Chemother 54: 999-1006 [Abstract] [Full Text]  
  • Coste, A. T., Karababa, M., Ischer, F., Bille, J., Sanglard, D. (2004). TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2. Eukaryot Cell 3: 1639-1652 [Abstract] [Full Text]  
  • Bellamine, A., Lepesheva, G. I., Waterman, M. R. (2004). Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology. J. Lipid Res. 45: 2000-2007 [Abstract] [Full Text]  
  • Karababa, M., Coste, A. T., Rognon, B., Bille, J., Sanglard, D. (2004). Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters. Antimicrob. Agents Chemother. 48: 3064-3079 [Abstract] [Full Text]  
  • Barker, K. S., Crisp, S., Wiederhold, N., Lewis, R. E., Bareither, B., Eckstein, J., Barbuch, R., Bard, M., Rogers, P. D. (2004). Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 54: 376-385 [Abstract] [Full Text]  
  • Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., Kusch, H., Morschhauser, J., Rogers, P. D. (2004). Proteomic Analysis of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 48: 2733-2735 [Abstract] [Full Text]  
  • Shukla, S., Ambudkar, S. V., Prasad, R. (2004). Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. J Antimicrob Chemother 54: 38-45 [Abstract] [Full Text]  
  • Kaur, R., Castano, I., Cormack, B. P. (2004). Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria. Antimicrob. Agents Chemother. 48: 1600-1613 [Abstract] [Full Text]  
  • Bennett, J. E., Izumikawa, K., Marr, K. A. (2004). Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis. Antimicrob. Agents Chemother. 48: 1773-1777 [Abstract] [Full Text]  
  • Frade, J. P., Warnock, D. W., Arthington-Skaggs, B. A. (2004). Rapid Quantification of Drug Resistance Gene Expression in Candida albicans by Reverse Transcriptase LightCycler PCR and Fluorescent Probe Hybridization. J. Clin. Microbiol. 42: 2085-2093 [Abstract] [Full Text]  
  • Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G., White, T. C. (2004). The Candida albicans Lanosterol 14-{alpha}-Demethylase (ERG11) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs. Antimicrob. Agents Chemother. 48: 1136-1144 [Abstract] [Full Text]  
  • Afeltra, J., Vitale, R. G., Mouton, J. W., Verweij, P. E. (2004). Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole. Antimicrob. Agents Chemother. 48: 1335-1343 [Abstract] [Full Text]  
  • Leber, R., Fuchsbichler, S., Klobucnikova, V., Schweighofer, N., Pitters, E., Wohlfarter, K., Lederer, M., Landl, K., Ruckenstuhl, C., Hapala, I., Turnowsky, F. (2003). Molecular Mechanism of Terbinafine Resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 47: 3890-3900 [Abstract] [Full Text]  
  • Shukla, S., Saini, P., Smriti, , Jha, S., Ambudkar, S. V., Prasad, R. (2003). Functional Characterization of Candida albicans ABC Transporter Cdr1p. Eukaryot Cell 2: 1361-1375 [Abstract] [Full Text]  
  • Jain, P., Akula, I., Edlind, T. (2003). Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors. Antimicrob. Agents Chemother. 47: 3195-3201 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., Bille, J. (2003). Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents. Antimicrob. Agents Chemother. 47: 2404-2412 [Abstract] [Full Text]  
  • Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., Sullivan, D. J. (2003). Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47: 2424-2437 [Abstract] [Full Text]  
  • Mukherjee, P. K., Chandra, J., Kuhn, D. M., Ghannoum, M. A. (2003). Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols. Infect. Immun. 71: 4333-4340 [Abstract] [Full Text]  
  • Burger, C., Rondet, S., Benveniste, P., Schaller, H. (2003). Virus-induced silencing of sterol biosynthetic genes: identification of a Nicotiana tabacum L. obtusifoliol-14{alpha}-demethylase (CYP51) by genetic manipulation of the sterol biosynthetic pathway in Nicotiana benthamiana L.. J Exp Bot 54: 1675-1683 [Abstract] [Full Text]  
  • Niewerth, M., Kunze, D., Seibold, M., Schaller, M., Korting, H. C., Hube, B. (2003). Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors. Antimicrob. Agents Chemother. 47: 1805-1817 [Abstract] [Full Text]  
  • Gauthier, C., Weber, S., Alarco, A.-M., Alqawi, O., Daoud, R., Georges, E., Raymond, M. (2003). Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters. Antimicrob. Agents Chemother. 47: 1543-1554 [Abstract] [Full Text]  
  • Marchetti, O., Moreillon, P., Entenza, J. M., Vouillamoz, J., Glauser, M. P., Bille, J., Sanglard, D. (2003). Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes. Antimicrob. Agents Chemother. 47: 1565-1570 [Abstract] [Full Text]  
  • Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., Perlin, D. S. (2003). Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole. Antimicrob. Agents Chemother. 47: 1719-1726 [Abstract] [Full Text]  
  • Barker, K. S., Pearson, M. M., Rogers, P. D. (2003). Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother 51: 1131-1140 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 47: 1220-1227 [Abstract] [Full Text]  
  • Noel, T., Francois, F., Paumard, P., Chastin, C., Brethes, D., Villard, J. (2003). Flucytosine-Fluconazole Cross-Resistance in Purine-Cytosine Permease-Deficient Candida lusitaniae Clinical Isolates: Indirect Evidence of a Fluconazole Uptake Transporter. Antimicrob. Agents Chemother. 47: 1275-1284 [Abstract] [Full Text]  
  • Brun, S., Aubry, C., Lima, O., Filmon, R., Berges, T., Chabasse, D., Bouchara, J.-P. (2003). Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother. 47: 847-853 [Abstract] [Full Text]  
  • Redding, S. W., Kirkpatrick, W. R., Saville, S., Coco, B. J., White, W., Fothergill, A., Rinaldi, M., Eng, T., Patterson, T. F., Lopez-Ribot, J. (2003). Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation. J. Clin. Microbiol. 41: 619-622 [Abstract] [Full Text]  
  • Mukherjee, P. K., Leidich, S. D., Isham, N., Leitner, I., Ryder, N. S., Ghannoum, M. A. (2003). Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine. Antimicrob. Agents Chemother. 47: 82-86 [Abstract] [Full Text]  
  • Zwiers, L.-H., Stergiopoulos, I., Van Nistelrooy, J. G. M., De Waard, M. A. (2002). ABC Transporters and Azole Susceptibility in Laboratory Strains of the Wheat Pathogen Mycosphaerella graminicola. Antimicrob. Agents Chemother. 46: 3900-3906 [Abstract] [Full Text]  
  • Wada, S.-i., Niimi, M., Niimi, K., Holmes, A. R., Monk, B. C., Cannon, R. D., Uehara, Y. (2002). Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties. J. Biol. Chem. 277: 46809-46821 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2002). Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis. Antimicrob. Agents Chemother. 46: 3412-3417 [Abstract] [Full Text]  
  • Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., Watanabe, N. (2002). Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect. Antimicrob. Agents Chemother. 46: 3113-3117 [Abstract] [Full Text]  
  • Hayashi, K., Schoonbeek, H.-j., De Waard, M. A. (2002). Bcmfs1, a Novel Major Facilitator Superfamily Transporter from Botrytis cinerea, Provides Tolerance towards the Natural Toxic Compounds Camptothecin and Cercosporin and towards Fungicides. Appl. Environ. Microbiol. 68: 4996-5004 [Abstract] [Full Text]  
  • Moran, G., Sullivan, D., Morschhauser, J., Coleman, D. (2002). The Candida dubliniensis CdCDR1 Gene Is Not Essential for Fluconazole Resistance. Antimicrob. Agents Chemother. 46: 2829-2841 [Abstract] [Full Text]  
  • Pagani, J.-L., Chave, J.-P., Casjka, C., Glauser, M.-P., Bille, J. (2002). Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 50: 231-240 [Abstract] [Full Text]  
  • Perea, S., Lopez-Ribot, J. L., Wickes, B. L., Kirkpatrick, W. R., Dib, O. P., Bachmann, S. P., Keller, S. M., Martinez, M., Patterson, T. F. (2002). Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis. Antimicrob. Agents Chemother. 46: 1695-1703 [Abstract] [Full Text]  
  • White, T. C., Holleman, S., Dy, F., Mirels, L. F., Stevens, D. A. (2002). Resistance Mechanisms in Clinical Isolates of Candida albicans. Antimicrob. Agents Chemother. 46: 1704-1713 [Abstract] [Full Text]  
  • Tsuchimori, N., Hayashi, R., Kitamoto, N., Asai, K., Kitazaki, T., Iizawa, Y., Itoh, K., Okonogi, K. (2002). In Vitro and In Vivo Antifungal Activities of TAK-456, a Novel Oral Triazole with a Broad Antifungal Spectrum. Antimicrob. Agents Chemother. 46: 1388-1393 [Abstract] [Full Text]  
  • Arikan, S., Ostrosky-Zeichner, L., Lozano-Chiu, M., Paetznick, V., Gordon, D., Wallace, T., Rex, J. H. (2002). In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates. J. Clin. Microbiol. 40: 1406-1412 [Abstract] [Full Text]  
  • Martinez, M., Lopez-Ribot, J. L., Kirkpatrick, W. R., Bachmann, S. P., Perea, S., Ruesga, M. T., Patterson, T. F. (2002). Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 49: 515-524 [Abstract] [Full Text]  
  • Nakamura, K., Niimi, M., Niimi, K., Holmes, A. R., Yates, J. E., Decottignies, A., Monk, B. C., Goffeau, A., Cannon, R. D. (2001). Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters. Antimicrob. Agents Chemother. 45: 3366-3374 [Abstract] [Full Text]  
  • Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhauser, J. (2001). MDR1-Mediated Drug Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 45: 3416-3421 [Abstract] [Full Text]  
  • Kontoyiannis, D. P., May ;, G. S., De Backer, M. D., Luyten, W. H. M. L., Bossche, H. V. (2001). Identification of Azole-Responsive Genes by Microarray Technology: Why Are We Missing the Efflux Transporter Genes?. Antimicrob. Agents Chemother. 45: 3674-3676 [Full Text]  
  • Nakayama, H., Nakayama, N., Arisawa, M., Aoki, Y. (2001). In Vitro and In Vivo Effects of 14alpha -Demethylase (ERG11) Depletion in Candida glabrata. Antimicrob. Agents Chemother. 45: 3037-3045 [Abstract] [Full Text]  
  • Perea, S., Lopez-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillan, R. A., Martinez, M., Calabrese, D., Sanglard, D., Patterson, T. F. (2001). Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 45: 2676-2684 [Abstract] [Full Text]  
  • Safdar, A., Chaturvedi, V., Cross, E. W., Park, S., Bernard, E. M., Armstrong, D., Perlin, D. S. (2001). Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center. Antimicrob. Agents Chemother. 45: 2129-2133 [Abstract] [Full Text]  
  • Chen, X. J. (2001). Activity of the Kluyveromyces lactis Pdr5 Multidrug Transporter Is Modulated by the Sit4 Protein Phosphatase. J. Bacteriol. 183: 3939-3948 [Abstract] [Full Text]  
  • Maebashi, K., Niimi, M., Kudoh, M., Fischer, F. J., Makimura, K., Niimi, K., Piper, R. J., Uchida, K., Arisawa, M., Cannon, R. D., Yamaguchi, H. (2001). Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J Antimicrob Chemother 47: 527-536 [Abstract] [Full Text]  
  • Staib, P., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhäuser, J. (2001). Isogenic Strain Construction and Gene Targeting in Candida dubliniensis. J. Bacteriol. 183: 2859-2865 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Bille, J. (2001). Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45: 1174-1183 [Abstract] [Full Text]  
  • PINA-VAZ, C., SANSONETTY, F., RODRIGUES, A. G., COSTA-DE-OLIVEIRA, S., MARTINEZ-DE-OLIVEIRA, J., FONSECA, A. F. (2001). Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy. J Med Microbiol 50: 375-382 [Abstract] [Full Text]  
  • Beckerman, J., Chibana, H., Turner, J., Magee, P. T. (2001). Single-Copy IMH3 Allele Is Sufficient To Confer Resistance to Mycophenolic Acid in Candida albicans and To Mediate Transformation of Clinical Candida Species. Infect. Immun. 69: 108-114 [Abstract] [Full Text]  
  • Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., Moreillon, P. (2000). Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans. Antimicrob. Agents Chemother. 44: 2932-2938 [Abstract] [Full Text]  
  • Calabrese, D., Bille, J., Sanglard, D. (2000). A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146: 2743-2754 [Abstract] [Full Text]  
  • BOUCHARA, J.-P., ZOUHAIR, R., LE BOUDOUIL, S., RENIER, G., FILMON, R., CHABASSE, D., HALLET, J.-N., DEFONTAINE, A. (2000). In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol 49: 977-984 [Abstract] [Full Text]  
  • Mizutani, S., Endo, M., Ino-ue, T., Kurasawa, M., Uno, Y., Saito, H., Onogi, K., Kato, I., Takesako, K. (2000). CD4+-T-Cell-Mediated Resistance to Systemic Murine Candidiasis Induced by a Membrane Fraction of Candida albicans. Antimicrob. Agents Chemother. 44: 2653-2658 [Abstract] [Full Text]  
  • Henry, K. W., Nickels, J. T., Edlind, T. D. (2000). Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors. Antimicrob. Agents Chemother. 44: 2693-2700 [Abstract] [Full Text]  
  • Lyons, C. N., White, T. C. (2000). Transcriptional Analyses of Antifungal Drug Resistance in Candida albicans. Antimicrob. Agents Chemother. 44: 2296-2303 [Abstract] [Full Text]  
  • Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., Sanglard, D. (2000). Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans. Antimicrob. Agents Chemother. 44: 2373-2381 [Abstract] [Full Text]  
  • Arthington-Skaggs, B. A., Warnock, D. W., Morrison, C. J. (2000). Quantitation of Candida albicans Ergosterol Content Improves the Correlation between In Vitro Antifungal Susceptibility Test Results and In Vivo Outcome after Fluconazole Treatment in a Murine Model of Invasive Candidiasis. Antimicrob. Agents Chemother. 44: 2081-2085 [Abstract] [Full Text]  
  • Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., Scalise, G. (2000). Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44: 1578-1584 [Abstract] [Full Text]  
  • Maesaki, S., Hossain, M. A., Miyazaki, Y., Tomono, K., Tashiro, T., Kohno, S. (2000). Efficacy of FK463, a (1,3)-beta -D-Glucan Synthase Inhibitor, in Disseminated Azole-Resistant Candida albicans Infection in Mice. Antimicrob. Agents Chemother. 44: 1728-1730 [Abstract] [Full Text]  
  • Timpel, C., Zink, S., Strahl-Bolsinger, S., Schröppel, K., Ernst, J. (2000). Morphogenesis, Adhesive Properties, and Antifungal Resistance Depend on the Pmt6 Protein Mannosyltransferase in the Fungal Pathogen Candida albicans. J. Bacteriol. 182: 3063-3071 [Abstract] [Full Text]  
  • Chen, X. J., Bauer, B. E., Kuchler, K., Clark-Walker, G. D. (2000). Positive and Negative Control of Multidrug Resistance by the Sit4 Protein Phosphatase in Kluyveromyces lactis. J. Biol. Chem. 275: 14865-14872 [Abstract] [Full Text]  
  • Wu, T., Wright, K., Hurst, S. F., Morrison, C. J. (2000). Enhanced Extracellular Production of Aspartyl Proteinase, a Virulence Factor, by Candida albicans Isolates following Growth in Subinhibitory Concentrations of Fluconazole. Antimicrob. Agents Chemother. 44: 1200-1208 [Abstract] [Full Text]  
  • Bammert, G. F., Fostel, J. M. (2000). Genome-Wide Expression Patterns in Saccharomyces cerevisiae: Comparison of Drug Treatments and Genetic Alterations Affecting Biosynthesis of Ergosterol. Antimicrob. Agents Chemother. 44: 1255-1265 [Abstract] [Full Text]  
  • Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., Kohn, L. M. (2000). Evolution of Drug Resistance in Experimental Populations of Candida albicans. J. Bacteriol. 182: 1515-1522 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»